Home
Healthcare
Healthcare & Pharmaceuticals
Minoxidil and Finasteride API Market Size, Industry | 2031

Minoxidil and Finasteride API Market

Name: Growth Market Reports
Address: 500 East E Street, Ontario, 91764, USA
Telephone: +1 909 414 1393

Segments - by Type (Minoxidil API and Finasteride API), Disease Type (Minoxidil API [Alopecia Treatment and Hypertension] and Finasteride API [Alopecia Treatment, BPH Treatment, and Other]), Route of Administration (Topical, Oral, and Injectable), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023– 2031

HC-4875
4.4 Rating
130 Pages

09-09-2022
70 Reviews

Author :

Raksha Sharma

Fact-checked by :

Vineet Pandey

Editor :

Vishal Golekar

Report Description

Minoxidil and Finasteride API Market Outlook

The global minoxidil and finasteride API market size was USD 153.4 Mn in 2022 and is likely to reach USD 262.9 Mn by 2031, expanding at a CAGR of 6.1% during 2023-2031. The market growth is attributed to the increasing cases of hair loss and the rising awareness regarding medications for hair loss treatment among patients globally.

Minoxidil (C9H15N5O) medications are available in two forms to treat various conditions. Minoxidil is taken orally to treat high blood pressure, and it is applied topically to treat hair loss and baldness. Finasteride is commonly prescribed to treat the symptoms of benign prostatic hyperplasia (BPH) and male pattern hair loss (androgenic alopecia). Finasteride's empirical formula is C23H36N2O2 and its molecular weight is 372.55 gms. Finasteride increases the number of scalp hairs in men who are experiencing hair loss.

Macro-economic Factors

Growing Demand for Alopecia Treatment

The growing geriatric population worldwide is one of the key factors boosting market growth as the aging population is mostly facing the issue of gradual thinning of hair. Improving healthcare infrastructure and increasing awareness about various effective therapies are the main factors pushing the demand for alopecia treatment.

COVID-19 Impact on Minoxidil and Finasteride API Market

The COVID-19 pandemic adversely impacted the global minoxidil and finasteride API market due to sudden disruption in the supply chain, which resulted in a harsh financial impact on industries and financial markets. Manufacturers of minoxidil and finasteride API were impacted during the pandemic, due to restrictions and the closure of global industries. Due to global transportation restrictions, raw material import and export were severely hampered.

Following COVID-19, it is expected that high R&D expenditure in Minoxidil and Finasteride API will fuel the market in the near future. Increasing support from various governments and environmentalists through investments in the manufacture of Minoxidil and Finasteride API, on the other hand, is expected to fuel the market following the pandemic.

Minoxidil and Finasteride API Market Dynamics

Drivers

Increasing demand for alopecia treatments

The rapid growth in the number of alopecia patients with significant hair loss can increase the use of minoxidil and finasteride APIs. Alopecia areata disease happens when an immune system attacks hair follicles and causes hair loss. As per the American Hair Loss Association (AHLA), more than 90% of hair loss is caused by Androgenetic Alopecia and also around 32 million men and 20 million women above the 35 age group are suffering from hair loss which is increasing the demand for alopecia treatments.

Pattern Hair Loss in Men and Women

Rising health issues such as cancer, hypertension, depression, arthritis, and cardiovascular diseases and to cure these diseases, patients need specific medication dosages which in turn results in significant hair loss. During, the cancer treatment process, especially in chemotherapy patients lose a significant amount of hair. Increasing demand for Minoxidil oil and medication as it helps patients with hair regrowth and nourishment which drives the global market.

Restraints

Side effects of Minoxidil and Finasteride

Minoxidil is a widely used popular and highly medication, and it has a number of side effects that can hamper the global market. Minoxidil and Finasteride treatment is expensive compared to other types of treatment and skin irritation near or at the application site is the most common side effect of minoxidil. Minoxidil skin irritation can cause itching and scale in some people. These factors are expected to hinder market growth.

Opportunities

Growing consumer spending on hair care products

The rising trend of maintaining long hair among men and the adoption of multiple hairstyles has resulted in an increase in the consumption of hair styling products that can create lucrative opportunities for the market during the forecast period. Increasing awareness about hair care among men & women and the rising adoption of hair care and styling products are expected to contribute to the growth of the market.

Scope of Minoxidil and Finasteride API Market Report

The report on the global Minoxidil and Finasteride API market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes	Details
Report Title	Minoxidil and Finasteride API Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast
Base Year	2022
Historic Data	2020–2021
Forecast Period	2023–2031
Segmentation	Disease Type (Minoxidil API (Alopecia treatment and Hypertension), Finasteride API (Alopecia treatment, BPH treatment, and Other)), and Route of Administration (Topical, Oral, and Injectable)
Regional Scope	Regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)
Report Coverage	Company Share, Minoxidil and Finasteride API Market Size and Analysis, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
Key Players Covered	Dr. Reddy’s Laboratories Ltd; Global Calcium PVT LTD; Global Pharma; Samex Overseas; Ralington Pharma; ICROM; Beloor Bayir; Flamma Group; SynZeal Research Pvt; Curia global; Tiefenbacher API + Ingredients; and Taj Pharmaceuticals

Minoxidil and Finasteride API Market Segmental Outlook

Why is the Minoxidil API More Prevalent than the Finasteride API?

On the basis of type, the market is bifurcated into a Minoxidil API and Finasteride API. The Minoxidil API segment holds a significant share of the market during the forecast period as it is safe for use for both men and women for the treatment of alopecia. Minoxidil helps slow the progress of hair loss and promotes the regrowth of lost hair and it is widely used as one of the most effective treatments for hair loss and baldness which can further boost the demand for Minoxidil API.

The Finasteride API segment is expected to register a considerable CAGR during the forecast period owing to the increasing benign prostatic hyperplasia in men and Finasteride API is widely used to cure the disease. It is a medication used to treat pattern hair loss disease in men which is known as androgenetic alopecia.

In men with pattern hair loss, the balding scalp contains increased amounts of DHT and miniaturized hair follicles compared with the hairy scalp. Finasteride API decreases the scalp and DHT concentration in androgenetic alopecia patients. It is taken by mouth and can be used to treat excessive hair growth in women.

Based on disease type, the market is fragmented into Minoxidil API (Alopecia treatment, Hypertension), Finasteride API (Alopecia treatment, BPH treatment, Other). The Minoxidil API segment is held a substantial share of the market, owing to the growing demand for hair loss and hypertension treatments.

In terms of the Route of Administration, the market is fragmented into topical, oral, and injectable. The topical category held a considerable share of the market over the forecast period, due as it is easy to apply and is completely non-invasive in nature.

Minoxidil and Finasteride API Market Regional Outlook

The global minoxidil and finasteride API Market is expected to maintain its dominance over the forecast period as a result of the rising API production landscape in developing economies such as China and India, which is expected to positively impact market growth.

The rising prevalence of BPH (benign prostatic hyperplasia) due to an aging population is projected to drive the market in this region. The market in Europe is expected to grow at a rapid pace due to the increasing use of non-invasive treatment, which is anticipated to support the demand for minoxidil and finasteride.

Key Benefits for Industry Participants & Stakeholders

In-depth Analysis of the Global Minoxidil and Finasteride API Market
Historical, Current, and Projected Market Size in terms of Value
Potential & Niche Segments and Regions Exhibiting Promising Growth Covered
Industry Drivers, Restraints, and Opportunities Covered in the Study
Recent Industry Trends and Developments
Competitive Landscape & Strategies of Key Players
Neutral Perspective on Global Minoxidil and Finasteride API Market Performance

Segments

Type

Minoxidil API
Finasteride API

Disease Type

Minoxidil API
- Alopecia treatment
- Hypertension
Finasteride API
- Alopecia treatment
- BPH treatment
- Other

Route of Administration

Topical
Oral
Injectable

Region

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Key Players

Dr. Reddy’s Laboratories Ltd
Global Calcium PVT LTD
Global Pharma
Samex Overseas
Ralington Pharma
ICROM
Beloor Bayir
Flamma Group
SynZeal Research Pvt
Curia global
Tiefenbacher API + Ingredients
Taj Pharmaceuticals

Competitive Landscape

Manufacturers operating in the global minoxidil and finasteride API market are Dr. Reddy’s Laboratories Ltd; Global Calcium PVT LTD; Global Pharma; Samex Overseas; Ralington Pharma; ICROM; Beloor Bayir; Flamma Group; SynZeal Research Pvt; Curia global; Tiefenbacher API + Ingredients; and Taj Pharmaceuticals.
Market players are pursuing key strategies such as collaborations, mergers & acquisitions, and geographic expansion to create more opportunities in the global minoxidil and finasteride API market.

Table Of Content

Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Minoxidil and Finasteride API Market Overview
   4.1 Introduction
      4.1.1 Market Taxonomy
      4.1.2 Market Definition
      4.1.3 Macro-Economic Factors Impacting the Market Growth
   4.2 Minoxidil and Finasteride API Market Dynamics
      4.2.1 Market Drivers
      4.2.2 Market Restraints
      4.2.3 Market Opportunity
   4.3 Minoxidil and Finasteride API Market - Supply Chain Analysis
      4.3.1 List of Key Suppliers
      4.3.2 List of Key Distributors
      4.3.3 List of Key Consumers
   4.4 Key Forces Shaping the Minoxidil and Finasteride API Market
      4.4.1 Bargaining Power of Suppliers
      4.4.2 Bargaining Power of Buyers
      4.4.3 Threat of Substitution
      4.4.4 Threat of New Entrants
      4.4.5 Competitive Rivalry
   4.5 Global Minoxidil and Finasteride API Market Size & Forecast, 2015-2030
      4.5.1 Minoxidil and Finasteride API Market Size and Y-o-Y Growth
      4.5.2 Minoxidil and Finasteride API Market Absolute $ Opportunity
Chapter 5 Global Minoxidil and Finasteride API Market Analysis and Forecast By Types
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities By Types
      5.1.2 Basis Point Share (BPS) Analysis By Types
      5.1.3 Absolute $ Opportunity Assessment By Types
   5.2 Minoxidil and Finasteride API Market Size Forecast By Types
      5.2.1 Minoxidil API
      5.2.2 Finasteride API
   5.3 Market Attractiveness Analysis By Types
Chapter 6 Global Minoxidil and Finasteride API Market Analysis and Forecast By Disease Type
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities By Disease Type
      6.1.2 Basis Point Share (BPS) Analysis By Disease Type
      6.1.3 Absolute $ Opportunity Assessment By Disease Type
   6.2 Minoxidil and Finasteride API Market Size Forecast By Disease Type
      6.2.1 Minoxidil API
         6.2.1.1 Alopecia treatment
         6.2.1.2 Hypertension
      6.2.2 Finasteride API
         6.2.2.1 Alopecia treatment
         6.2.2.2 BPH treatment
         6.2.2.3 Other
   6.3 Market Attractiveness Analysis By Disease Type
Chapter 7 Global Minoxidil and Finasteride API Market Analysis and Forecast By Route of Administration
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities By Route of Administration
      7.1.2 Basis Point Share (BPS) Analysis By Route of Administration
      7.1.3 Absolute $ Opportunity Assessment By Route of Administration
   7.2 Minoxidil and Finasteride API Market Size Forecast By Route of Administration
      7.2.1 Topical
      7.2.2 Oral
      7.2.3 Injectable
   7.3 Market Attractiveness Analysis By Route of Administration
Chapter 8 Global Minoxidil and Finasteride API Market Analysis and Forecast by Region
   8.1 Introduction
      8.1.1 Key Market Trends & Growth Opportunities by Region
      8.1.2 Basis Point Share (BPS) Analysis by Region
      8.1.3 Absolute $ Opportunity Assessment by Region
   8.2 Minoxidil and Finasteride API Market Size Forecast by Region
      8.2.1 North America
      8.2.2 Europe
      8.2.3 Asia Pacific
      8.2.4 Latin America
      8.2.5 Middle East & Africa (MEA)
   8.3 Market Attractiveness Analysis by Region
Chapter 9 Coronavirus Disease (COVID-19) Impact
   9.1 Introduction
   9.2 Current & Future Impact Analysis
   9.3 Economic Impact Analysis
   9.4 Government Policies
   9.5 Investment Scenario
Chapter 10 North America Minoxidil and Finasteride API Analysis and Forecast
   10.1 Introduction
   10.2 North America Minoxidil and Finasteride API Market Size Forecast by Country
      10.2.1 U.S.
      10.2.2 Canada
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 North America Minoxidil and Finasteride API Market Size Forecast By Types
      10.6.1 Minoxidil API
      10.6.2 Finasteride API
   10.7 Basis Point Share (BPS) Analysis By Types
   10.8 Absolute $ Opportunity Assessment By Types
   10.9 Market Attractiveness Analysis By Types
   10.10 North America Minoxidil and Finasteride API Market Size Forecast By Disease Type
      10.10.1 Minoxidil API
         10.10.1.1 Alopecia treatment
         10.10.1.2 Hypertension
      10.10.2 Finasteride API
         10.10.2.1 Alopecia treatment
         10.10.2.2 BPH treatment
         10.10.2.3 Other
   10.11 Basis Point Share (BPS) Analysis By Disease Type
   10.12 Absolute $ Opportunity Assessment By Disease Type
   10.13 Market Attractiveness Analysis By Disease Type
   10.14 North America Minoxidil and Finasteride API Market Size Forecast By Route of Administration
      10.14.1 Topical
      10.14.2 Oral
      10.14.3 Injectable
   10.15 Basis Point Share (BPS) Analysis By Route of Administration
   10.16 Absolute $ Opportunity Assessment By Route of Administration
   10.17 Market Attractiveness Analysis By Route of Administration
Chapter 11 Europe Minoxidil and Finasteride API Analysis and Forecast
   11.1 Introduction
   11.2 Europe Minoxidil and Finasteride API Market Size Forecast by Country
      11.2.1 Germany
      11.2.2 France
      11.2.3 Italy
      11.2.4 U.K.
      11.2.5 Spain
      11.2.6 Russia
      11.2.7 Rest of Europe
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Europe Minoxidil and Finasteride API Market Size Forecast By Types
      11.6.1 Minoxidil API
      11.6.2 Finasteride API
   11.7 Basis Point Share (BPS) Analysis By Types
   11.8 Absolute $ Opportunity Assessment By Types
   11.9 Market Attractiveness Analysis By Types
   11.10 Europe Minoxidil and Finasteride API Market Size Forecast By Disease Type
      11.10.1 Minoxidil API
         11.10.1.1 Alopecia treatment
         11.10.1.2 Hypertension
      11.10.2 Finasteride API
         11.10.2.1 Alopecia treatment
         11.10.2.2 BPH treatment
         11.10.2.3 Other
   11.11 Basis Point Share (BPS) Analysis By Disease Type
   11.12 Absolute $ Opportunity Assessment By Disease Type
   11.13 Market Attractiveness Analysis By Disease Type
   11.14 Europe Minoxidil and Finasteride API Market Size Forecast By Route of Administration
      11.14.1 Topical
      11.14.2 Oral
      11.14.3 Injectable
   11.15 Basis Point Share (BPS) Analysis By Route of Administration
   11.16 Absolute $ Opportunity Assessment By Route of Administration
   11.17 Market Attractiveness Analysis By Route of Administration
Chapter 12 Asia Pacific Minoxidil and Finasteride API Analysis and Forecast
   12.1 Introduction
   12.2 Asia Pacific Minoxidil and Finasteride API Market Size Forecast by Country
      12.2.1 China
      12.2.2 Japan
      12.2.3 South Korea
      12.2.4 India
      12.2.5 Australia
      12.2.6 South East Asia (SEA)
      12.2.7 Rest of Asia Pacific (APAC)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Asia Pacific Minoxidil and Finasteride API Market Size Forecast By Types
      12.6.1 Minoxidil API
      12.6.2 Finasteride API
   12.7 Basis Point Share (BPS) Analysis By Types
   12.8 Absolute $ Opportunity Assessment By Types
   12.9 Market Attractiveness Analysis By Types
   12.10 Asia Pacific Minoxidil and Finasteride API Market Size Forecast By Disease Type
      12.10.1 Minoxidil API
         12.10.1.1 Alopecia treatment
         12.10.1.2 Hypertension
      12.10.2 Finasteride API
         12.10.2.1 Alopecia treatment
         12.10.2.2 BPH treatment
         12.10.2.3 Other
   12.11 Basis Point Share (BPS) Analysis By Disease Type
   12.12 Absolute $ Opportunity Assessment By Disease Type
   12.13 Market Attractiveness Analysis By Disease Type
   12.14 Asia Pacific Minoxidil and Finasteride API Market Size Forecast By Route of Administration
      12.14.1 Topical
      12.14.2 Oral
      12.14.3 Injectable
   12.15 Basis Point Share (BPS) Analysis By Route of Administration
   12.16 Absolute $ Opportunity Assessment By Route of Administration
   12.17 Market Attractiveness Analysis By Route of Administration
Chapter 13 Latin America Minoxidil and Finasteride API Analysis and Forecast
   13.1 Introduction
   13.2 Latin America Minoxidil and Finasteride API Market Size Forecast by Country
      13.2.1 Brazil
      13.2.2 Mexico
      13.2.3 Rest of Latin America (LATAM)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Latin America Minoxidil and Finasteride API Market Size Forecast By Types
      13.6.1 Minoxidil API
      13.6.2 Finasteride API
   13.7 Basis Point Share (BPS) Analysis By Types
   13.8 Absolute $ Opportunity Assessment By Types
   13.9 Market Attractiveness Analysis By Types
   13.10 Latin America Minoxidil and Finasteride API Market Size Forecast By Disease Type
      13.10.1 Minoxidil API
         13.10.1.1 Alopecia treatment
         13.10.1.2 Hypertension
      13.10.2 Finasteride API
         13.10.2.1 Alopecia treatment
         13.10.2.2 BPH treatment
         13.10.2.3 Other
   13.11 Basis Point Share (BPS) Analysis By Disease Type
   13.12 Absolute $ Opportunity Assessment By Disease Type
   13.13 Market Attractiveness Analysis By Disease Type
   13.14 Latin America Minoxidil and Finasteride API Market Size Forecast By Route of Administration
      13.14.1 Topical
      13.14.2 Oral
      13.14.3 Injectable
   13.15 Basis Point Share (BPS) Analysis By Route of Administration
   13.16 Absolute $ Opportunity Assessment By Route of Administration
   13.17 Market Attractiveness Analysis By Route of Administration
Chapter 14 Middle East & Africa (MEA) Minoxidil and Finasteride API Analysis and Forecast
   14.1 Introduction
   14.2 Middle East & Africa (MEA) Minoxidil and Finasteride API Market Size Forecast by Country
      14.2.1 Saudi Arabia
      14.2.2 South Africa
      14.2.3 UAE
      14.2.4 Rest of Middle East & Africa (MEA)
   14.3 Basis Point Share (BPS) Analysis by Country
   14.4 Absolute $ Opportunity Assessment by Country
   14.5 Market Attractiveness Analysis by Country
   14.6 Middle East & Africa (MEA) Minoxidil and Finasteride API Market Size Forecast By Types
      14.6.1 Minoxidil API
      14.6.2 Finasteride API
   14.7 Basis Point Share (BPS) Analysis By Types
   14.8 Absolute $ Opportunity Assessment By Types
   14.9 Market Attractiveness Analysis By Types
   14.10 Middle East & Africa (MEA) Minoxidil and Finasteride API Market Size Forecast By Disease Type
      14.10.1 Minoxidil API
         14.10.1.1 Alopecia treatment
         14.10.1.2 Hypertension
      14.10.2 Finasteride API
         14.10.2.1 Alopecia treatment
         14.10.2.2 BPH treatment
         14.10.2.3 Other
   14.11 Basis Point Share (BPS) Analysis By Disease Type
   14.12 Absolute $ Opportunity Assessment By Disease Type
   14.13 Market Attractiveness Analysis By Disease Type
   14.14 Middle East & Africa (MEA) Minoxidil and Finasteride API Market Size Forecast By Route of Administration
      14.14.1 Topical
      14.14.2 Oral
      14.14.3 Injectable
   14.15 Basis Point Share (BPS) Analysis By Route of Administration
   14.16 Absolute $ Opportunity Assessment By Route of Administration
   14.17 Market Attractiveness Analysis By Route of Administration
Chapter 15 Competition Landscape
   15.1 Minoxidil and Finasteride API Market: Competitive Dashboard
   15.2 Global Minoxidil and Finasteride API Market: Market Share Analysis, 2021
   15.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
      15.3.1 Dr. Reddy’s Laboratories Ltd
      15.3.2 Global Calcium PVT LTD
      15.3.3 Global Pharma
      15.3.4 Samex Overseas
      15.3.5 Ralington Pharma
      15.3.6 ICROM
      15.3.7 Beloor Bayir
      15.3.8 Flamma Group
      15.3.9 SynZeal Research Pvt
      15.3.10 Curia global
      15.3.11 Tiefenbacher API + Ingredients
      15.3.12 Taj Pharmaceuticals

Methodology

Purchase Premium Report

Buy Now

Request For Sample

Request For Customization

Enquiry Before Buying

Speak With Analyst

Customize This Report

Ask for Research To Be Focused On Specific Regions or Segments
Receive Data As Per Your Format and Definition
Companies Profiled based on Your Requirements
Breaking Down Competitive Landscape as per Your Requirements
Any Level of Customization

Our Clients

Client Testinomials

We needed a highly accurate and precise report, which Growth Market Reports delivered promptly. The company compiled information from a wide array of reliable agencies and sourcess.It is extremely satisfactory to be working with you.
Strategy Head of Major Tech Company

We were very pleased to contact Growth Market Reports as they tailored reports precisely as per our requirements. As we are dealing with the aerospace and defense industry, we need reports of high accuracy and substantial quality.
Major Player in Defense Industry

Extremely delighted to have a well-crafted report on “Global Packaging Solutions Market Research Report” from your team. Thank you for providing me with all our requirements and for incorporating our suggestions.
CMO of Leading Packaging Company from USA

I had a good experience working with Growth Market Reports as they were very open to all constructive changes in the report. I found that the report had its charm embedded with ample of data.
Founder and Managing Partner of Major Korean Company

Our company has been working with Growth Market Reports for some years now and we are very happy with the quality of the reports provided by the company.I, on behalf of my organization, would like to thank you for offering professional reports.
Global Consulting Firm

Quick Contact

+1 909 414 1393

sales@growthmarketreports.com

Growth Market Report

Certified By

FAQ Section

Some frequently asked questions about this report!

1. Who are the major players operating in the market?

Major manufacturers include Tiefenbacher API + Ingredients; Taj Pharmaceuticals; Dr. Reddy’s Laboratories Ltd; Curia Global, Inc.; and Global Calcium PVT LTD.

2. Which macroeconomic factors affect the market?

Factors such as increased growing demand for alopecia treatment, growing demand for alopecia treatment, rising benign prostate hyperplasia and hypertension cases, and government regulations are analyzed in the final report.

3. Which is the base year calculated in the global Minoxidil and Finasteride API market report and what is the analysis period?

The base year considered for the Global Minoxidil and Finasteride API Market report is 2022. The complete analysis period is 2020 to 2031, wherein, 2020 to 2021 are the historic years, and the forecast is provided from 2023 to 2031.

4. What is the major Route of Administration of the global Minoxidil and Finasteride API market driving the market growth?

Topical and oral is the major Route of Administration of the global Minoxidil and Finasteride API market.

5. What is the impact of COVID-19 on the overall market during the years 2019 -2020?

The global Minoxidil and Finasteride API market were slightly impacted by the COVID-19 outbreak, owing to the disruption in the supply chain, with production facilities closing and many projects canceled as a result of the outbreak. However, following the COVID-19 impact, the minoxidil market is growing due to hair loss, and many hair problems that arise as a result of stress and other conditions, are expected the market is growing in the future.

6. What are the factors driving the growth of the global Minoxidil and Finasteride API market?

Growing demand for alopecia treatments, increasing prevalence of hypertension, growing prevalence of BPH (benign prostatic hyperplasia), and growing emphasis on enhancing physical appearance are the factors expected to drive the market growth during the forecast period.